India’s Use of Patent Opposition Mechanism as an Access to Drugs Strategy: An Empirical Analysis. JIPR [Internet]. 2024 Jul. 4 [cited 2026 May 13];29(4):253-64. Available from: https://or.niscpr.res.in/index.php/JIPR/article/view/3704